SPOK Stock Analysis: Buy, Sell, or Hold?
SPOK - Spok Holdings, Inc
$13.77
0.41 (3.07%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
22d
Get Alerted When SPOK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SPOK shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
✅ BUY SIGNAL: SPOK shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.94
Based on 3.9% avg growth
INTRINSIC VALUE TODAY
$9.90
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SPOK is currently trading at $13.77, which is considered extended relative to its 30-day fair value range of $13.00 to $13.46. The stock's valuation (Forward PE: 16.6) is in line with its historical norms (15.9). At these levels, the market is pricing in 1.3% annual earnings growth.
Technical Outlook: Technically, SPOK is in a strong downtrend. The price is approaching resistance at $13.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: SPOK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.00 (+52.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SPOK is in a strong downtrend. The price is approaching resistance at $13.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: SPOK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.00 (+52.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$13.00 -
$13.46
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 52.5% below Wall St target ($21.00)
- BULLISH: Expecting earnings turnaround to 1.3% growth with -2.9% revenue growth
Fair Price Analysis
30-Day Fair Range
$13.00 -
$13.46
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$0.65
(4.7%)
Support & Resistance Levels
Support Level
$13.03
Resistance Level
$13.85
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
16.59
Wall Street Target
$21.00
(+52.5%)
Revenue Growth (YoY)
-2.9%
Earnings Growth (YoY)
-16.7%
Profit Margin
11.9%
Valuation Premium vs History
+1.3% premium
PE vs Historical
16.6 vs 15.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$13.95
(+1%)
2-Year Target
$14.13
(+3%)
3-Year Target
$14.31
(+4%)
3-Yr Target (if PE normalizes)
(PE: 17→16)
PE COMPRESSION
$13.72
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 3.7%)
$20.67
(+50%)
Base:
(SPY PE: 16.6, Growth: 3.7%)
$15.38
(+12%)
Bear:
(PE: 14.1, Growth: 3.7%)
$13.07
(-5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 16.60 | Current EPS (TTM): $0.80
Bull Case
$15.16
(+10%)
Analyst growth 3.7%, PE expands to 18.3
Base Case
$13.78
(+0%)
Market implied 3.7%, PE stable at 16.6
Bear Case
$9.03
(-34%)
Severe decline -20.0%, PE contracts to 14.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: February 01, 2026 6:24 PM ET
Data refreshes hourly during market hours. Next update: 7:24 PM
Data refreshes hourly during market hours. Next update: 7:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPOK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael W Wallace
SELL
10806 shares
2025-08-25
Vincent D Kelly
SELL
25000 shares
2025-08-21
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
